Currently, the repurposing of existing medications has emerged as a significant avenue for targeted therapy: metformin reprograms tryptophan metabolism to enhance CD8+ T cell function in colorectal cancer [16]; stiripentol, an anti-epileptic agent, can disrupt cellular DNA repair mechanisms, rendering tumor cells once again sensitive to radiotherapy and chemotherapy [17]. This evidence concerns the gene CD8A and neoplasm.